Exploratory Study of Single-port Robot-assisted Gastrectomy
NCT06201585 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2024-01-11
Summary
This clinical study was a prospective, single-center, single-arm exploratory study. Subjects who meet the inclusion criteria will be enrolled in this study, where surgeons will perform single-port robot-assisted gastrectomy, and explore and evaluate the safety and efficacy of this clinical application.
Conditions
Interventions
- DEVICE
-
SHURUI Endoscopic Surgical Robotic System (SR-ENS-600)
SHURUI Endoscopic Surgical Robotic System (SR-ENS-600)
Sponsors & Collaborators
-
Hebei Medical University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-01
- Primary Completion
- 2024-07-01
- Completion
- 2024-08-01
Countries
- China
Study Locations
More Related Trials
-
A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer
NCT04062058 ·Status: UNKNOWN ·Phase: PHASE2
-
Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer
NCT04795063 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Robotic Gastrectomy With 5th Arm
NCT07310888 ·Status: RECRUITING ·Phase: NA
-
Robotic Total Gastrectomy for Locally Advanced Proximal Gastric Cancer
NCT03524287 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Chemoradiation Plus PD-1 Antibody(SHR-1210) in Locally Advanced Proximal Stomach Adenocarcinoma
NCT03631615 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer
NCT05149807 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients
NCT03874871 ·Status: UNKNOWN
-
Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer
NCT01544413 ·Status: COMPLETED ·Phase: NA
-
Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer
NCT00209638 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase II Study for Robot Assisted Distal Gastrectomy
NCT01504997 ·Status: UNKNOWN ·Phase: PHASE2
-
Adjuvant Treatment With Serplulimab,Trastuzumab and SOX in the HER-2 Positive GC/GEJC
NCT06439550 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer
NCT01305993 ·Status: UNKNOWN ·Phase: PHASE2
-
Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric Cancer
NCT06478394 ·Status: RECRUITING
-
Diagnosis of Peritoneal Exfoliative Cytology-positive Gastric Cancer Based on Artificial Intelligence-driven Virtual Biopsy Technology
NCT06759467 ·Status: COMPLETED
-
A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer
NCT01839500 ·Status: COMPLETED
-
Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study
NCT06814548 ·Status: NOT_YET_RECRUITING
-
Trastuzumab Based Therapy in HER2 Positive AGC
NCT03024450 ·Status: COMPLETED
-
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
NCT07102901 ·Status: RECRUITING ·Phase: PHASE2
-
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
NCT06727981 ·Status: RECRUITING
-
Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer
NCT00587145 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer
NCT06499610 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer
NCT00209664 ·Status: SUSPENDED ·Phase: PHASE2
-
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study
NCT05753306 ·Status: RECRUITING ·Phase: PHASE2
-
Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer
NCT02873520 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy
NCT01804998 ·Status: COMPLETED ·Phase: NA